Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing countryJayastu Senapati, Tulika Seth, Mukul Aggarwal et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 13